Core Laboratories (CLB) Reports In-Line Q3 EPS, Q4 Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $10.19 -4.23%
Financial Fact:
Interest expense: 2.57M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Interest expense: 2.57M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q3 EPS of $0.83, in-line with the analyst estimate of $0.83. Revenue for the quarter came in at $197.3 million versus the consensus estimate of $201.06 million.
Core Laboratories sees Q4 2015 EPS of $0.63-$0.67, versus the consensus of $0.75. Core Laboratories sees Q4 2015 revenue of $180 million, versus the consensus of $191.94 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple (AAPL) Tops Q4 EPS by 11c, Beats on Revenue, Beats on iPhone sales, Misses China
- ONE Gas (OGS) Tops Q3 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Hinge Health, Inc. (HNGE) Tops Q3 EPS by 6c, raises Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
